7117 results
-
List item
Press briefing on the conclusion of the investigation of COVID-19 Vaccine AstraZeneca and thromboembolic events by the Pharmacovigilance Risk Assessment Committee (PRAC) (updated)
Virtual meeting, 18/03/2021, Last updated: 19/03/2021 -
List item
News: COVID-19 Vaccine AstraZeneca: benefits still outweigh the risks despite possible link to rare blood clots with low blood platelets (updated)
PRAC, Last updated: 19/03/2021 -
List item
Paediatric Committee (PDCO): 26-29 January 2021
Virtual meeting, from 26/01/2021 to 29/01/2021, Last updated: 11/03/2021 -
List item
Paediatric Committee (PDCO): 8-11 December 2020
Virtual meeting, from 08/12/2020 to 11/12/2020, Last updated: 01/03/2021 -
List item
Paediatric Committee (PDCO): 23-26 February 2021
Virtual meeting, from 23/02/2021 to 26/02/2021, Last updated: 23/02/2021 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 8-11 February 2021
European Medicines Agency, Amsterdam, the Netherlands, from 08/02/2021 to 11/02/2021, Last updated: 08/02/2021 -
List item
Paediatric Committee (PDCO): 10-13 November 2020
Virtual meeting, from 10/11/2020 to 13/11/2020, Last updated: 25/01/2021 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 26-29 October 2020
Virtual meeting, from 26/10/2020 to 29/10/2020, Last updated: 08/01/2021 -
List item
Paediatric Committee (PDCO): 13-16 October 2020
Virtual meeting, from 13/10/2020 to 16/10/2020, Last updated: 14/12/2020 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 6-9 July 2020
European Medicines Agency, Amsterdam, the Netherlands, from 06/07/2020 to 09/07/2020, Last updated: 10/12/2020 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 23-26 November 2020
Virtual meeting, from 23/11/2020 to 26/11/2020, Last updated: 27/11/2020 -
List item
News: Call for independent scientific experts to join EMA's Pharmacovigilance Risk Assessment Committee (PRAC) - deadline extended
PRAC, Last updated: 20/11/2020 -
List item
Paediatric Committee (PDCO): 1-4 September 2020
Virtual meeting, from 01/09/2020 to 04/09/2020, Last updated: 16/10/2020 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 14-17 April 2020
European Medicines Agency, Amsterdam, the Netherlands, from 14/04/2020 to 17/04/2020, Last updated: 14/10/2020 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 28 September-1 October 2020
Virtual meeting, from 28/09/2020 to 01/10/2020, Last updated: 29/09/2020 -
List item
Paediatric Committee (PDCO): 23-26 June 2020
European Medicines Agency, Amsterdam, The Netherlands, from 23/06/2020 to 26/06/2020, Last updated: 28/08/2020 -
List item
Paediatric Committee (PDCO): 25-28 February 2020
European Medicines Agency, Amsterdam, The Netherlands, from 25/02/2020 to 28/02/2020, Last updated: 28/08/2020 -
List item
Paediatric Committee (PDCO): 28-30 April 2020
European Medicines Agency, Amsterdam, The Netherlands, from 28/04/2020 to 30/04/2020, Last updated: 28/08/2020 -
List item
Paediatric Committee (PDCO): 9-11 December 2019
European Medicines Agency, Amsterdam, The Netherlands, from 09/12/2019 to 11/12/2019, Last updated: 02/07/2020 -
List item
Paediatric Committee (PDCO): 12-15 November 2019
European Medicines Agency, Amsterdam, The Netherlands, from 12/11/2019 to 15/11/2019, Last updated: 23/03/2020 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 9-12 March 2020
from 09/03/2020 to 12/03/2020, Last updated: 06/03/2020 -
List item
Paediatric Committee (PDCO): 24-27 March 2020
European Medicines Agency, Amsterdam, The Netherlands, from 24/03/2020 to 27/03/2020, Last updated: 25/02/2020 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 30 September-3 October 2019
European Medicines Agency, Amsterdam, the Netherlands, from 30/09/2019 to 03/10/2019, Last updated: 19/02/2020 -
List item
Paediatric Committee (PDCO): 28-31 January 2020
European Medicines Agency, Amsterdam, The Netherlands, from 28/01/2020 to 31/01/2020, Last updated: 30/01/2020 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 13-16 January 2020
European Medicines Agency, Spark building, Orlyplein 24, Amsterdam 1043 DP, The Netherlands, from 13/01/2020 to 16/01/2020, Last updated: 13/01/2020